These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 8944091)
21. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS; Van Noordin S; Krausz T; Davies KA J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [TBL] [Abstract][Full Text] [Related]
22. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Rojas B; Cuhna R; Zafirakis P; Ramirez JM; Lizan-garciía M; Zhao T; Foster CS Exp Eye Res; 2005 Sep; 81(3):313-25. PubMed ID: 16129099 [TBL] [Abstract][Full Text] [Related]
24. [The influence of ultraviolet radiation on HLA-DR+ and CD1a+ cells' number in systemic lupus erythematosus patients]. Lesiak A; Narbutt J; Kobos J; Sysa-Jedrzejowska A; Woźniacka A Przegl Lek; 2007; 64(9):563-7. PubMed ID: 18510077 [TBL] [Abstract][Full Text] [Related]
25. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus. Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105 [TBL] [Abstract][Full Text] [Related]
26. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
27. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
28. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
29. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Hahn BH; Anderson M; Le E; La Cava A Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553 [TBL] [Abstract][Full Text] [Related]
30. T cell subset composition in remission phase of systemic connective tissue diseases. Markeljević J; Marusić M; Uzarević B; Petrovecki M; Trutin-Ostović K; Cikes N; Batinić D; Babic-Naglic D; Horvat Z J Clin Lab Immunol; 1991 May; 35(1):33-9. PubMed ID: 1668288 [TBL] [Abstract][Full Text] [Related]
31. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Caligaris-Cappio F; Bergui L; Tesio L; Ziano R; Camussi G Clin Exp Immunol; 1985 Jan; 59(1):185-9. PubMed ID: 3156013 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [TBL] [Abstract][Full Text] [Related]
33. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915 [TBL] [Abstract][Full Text] [Related]
34. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus. Vieira QF; Kayser C; Kallas EG; Andrade LE J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155 [TBL] [Abstract][Full Text] [Related]
36. [Proliferation of large granular lymphocytes in patients with systemic lupus erythematosus]. Sampalo Lainz A; López-Gómez M; Jiménez-Alonso J Rev Clin Esp; 1995 Jun; 195(6):373-9. PubMed ID: 7644784 [TBL] [Abstract][Full Text] [Related]
37. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851 [TBL] [Abstract][Full Text] [Related]
38. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
39. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
40. Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus. Fortune F; Lehner T Clin Exp Immunol; 1988 Oct; 74(1):100-4. PubMed ID: 2975536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]